250
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Improvement of therapy-induced myelodysplastic syndrome by infusion of autologous CD34-positive hematopoietic progenitor cells without chemotherapy

, , , , , , , , , , , , , , & show all
Pages 3259-3262 | Received 15 Jun 2020, Accepted 27 Jul 2020, Published online: 28 Aug 2020
 

Acknowledgments

We are thankful to our patient who consented to additional genetic analysis and to the full report of her case. We are grateful to Drs. Françoise Norol (Apheresis unit, Pitié-Salpétrière Hospital, AP-HP, Paris, France) and Chloé Couzin (Cell therapy unit, Necker Hospital, AP-HP, Paris, France) for the cryopreservation of CD34-positive apheresis samples.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

Seiamak Bahram’s laboratory is supported by grants from the Agence Nationale de la Recherche (ANR) (ANR-11-LABX-0070_TRANSPLANTEX), the INSERM (UMR_S 1109), the Institut Universitaire de France (IUF), the University of Strasbourg (IDEX UNISTRA), the European regional development fund (European Union) INTERREG V program (project n°3.2 TRIDIAG) and MSD-Avenir grant AUTOGEN.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.